INGN
$64.41
Inogen
$1.23
1.95%
INGN
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.13)
Revenue:  $81.67 Mil
Tuesday
Aug 3
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when INGN reports earnings?
Beat
Meet
Miss

Where is INGN's stock price going from here?
Up
Flat
Down
Stock chart of INGN
Analysts
Summary of analysts' recommendations for INGN
Score
Grade
Pivots
Resistance
$70.37
$68.84
$66.01

$64.49

Support
$61.66
$60.14
$57.31
Tweet
Growth
Description
Inogen, Inc. is a medical technology company. It offers oxygen concentrator, cart, carry bags, backpacks, external battery chargers and universal power supply for obstructive pulmonary disease patients. The Company's products include Inogen One G3 and Inogen One G2. It sells its products in the United States and internationally. Inogen, Inc. is headquartered in Goleta, California.
Peers
InterCeptVertex PharmaceuticalsBioMarin PharmaceuticalRegeneron PharmaceuticalsUltragenyx PharmaceuticalBristol-Myers SquibbPfizerZoetisEli LillyMerck & Co.